查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1820376

2025 年至 2033 年新生兒篩檢市場規模、佔有率、趨勢及預測（按產品、技術、檢測類型和地區）

Newborn Screening Market Size, Share, Trends and Forecast by Product, Technology, Test Type, and Region, 2025-2033
出版日期: | 出版商: IMARC | 英文 136 Pages | 商品交期: 2-3個工作天內

價格

2024年，全球新生兒篩檢市場規模達10.893億美元。展望未來， IMARC Group預測，到2033年，該市場規模將達到18.181億美元，2025年至2033年的複合年成長率為5.9%。目前，北美佔據市場主導地位，2024年的市佔率將超過33.2%。這得歸功於人們日益增強的對新生兒重症早期發現意識、醫療技術的進步（旨在提高篩檢結果的準確性）以及政府的積極舉措。

隨著診斷技術的進步以及對新生兒疾病早期識別認知的提高，新生兒篩檢市場正在蓬勃發展。世界各國政府已實施了全面的新生兒篩檢計劃，涵蓋代謝、遺傳和內分泌疾病，這進一步增加了對這些疾病的先進篩檢試劑盒和系統的需求。串聯質譜和酶聯免疫吸附測定領域的進一步發展提高了檢測所需的靈敏度和特異性，從而提高了其整體應用率。先天性畸形和遺傳性代謝疾病發生率的上升使得早期診斷至關重要，這使得早期診斷成為公共衛生政策的重中之重。

美國已成為新生兒篩檢的重要區域市場。這得歸功於人們對早期疾病檢測及其在預防終身併發症方面作用的認知日益加深。政府強制推行的全面新生兒篩檢計畫在推動新生兒篩檢應用方面發揮了關鍵作用。串聯質譜和新一代定序等技術進步提高了檢測遺傳、代謝和感染性疾病的準確性和速度，促進了篩檢的廣泛應用。遺傳性疾病和代謝性疾病盛行率的上升進一步刺激了需求。公共和私人資金的增加支持了先進篩檢方法的研究和實施。此外，非侵入性篩檢技術的發展提供了更安全、更有效率的檢測選擇。此外，醫療保健提供者和政策制定者強調早期診斷和治療的長期成本節約，這進一步推動了篩檢的發展。

新生兒篩檢市場趨勢：

提高對早期疾病檢測的認知

家長們越來越意識到早期疾病檢測的重要性，因為它有助於提高治療效果、改善兒童生活品質並提供及時干預，這是推動新生兒篩檢市場發展的主要驅動力之一。此外，先天性疾病發生率的上升也是另一個重要的成長誘因。此外，據報道，在美國，每1,000名兒童中約有2至3名患有腦性麻痺。

有利的政府舉措

監管機構推出的政策通常涵蓋全面的疾病種類，並確保有效解決潛在的健康問題，這正在推動全球新生兒篩檢市場的發展。例如，2022年6月，加拿大曼尼托巴省政府機構宣布擴大其新生兒篩檢計劃，旨在將脊髓性肌肉萎縮症及其他疾病的篩檢範圍擴大到其他疾病。此外，各政府部門也強制要求新生兒出院前進行篩檢，對新生兒篩檢市場的整體成長產生了正面影響。

醫療科技的進步

主要參與者正在推進醫療技術，以改進新生兒篩檢方法，這是另一個重要的成長促進因素。此外，新興的篩檢技術鼓勵醫療保健提供者提供和​​採用這些服務，從而推動全球市場的發展。例如，2021年6月，德州衛生服務部推出了新生兒脊髓性肌肉萎縮症 (SMA) 篩檢。為此，Trivitron Healthcare 於2022年在印度AMTZ園區建立了一個卓越中心 (CoE)，該中心擁有最先進的研發和製造設施，用於基因組學、新生兒篩檢、代謝組學和分子診斷。此外，2023年1月，Masimo宣布推出其全新的先進嬰兒監護系統，使照顧者能夠即時監測嬰兒的資料。

目錄

第1章：前言

第2章：範圍與方法

  • 研究目標
  • 利害關係人
  • 資料來源
    • 主要來源
    • 二手資料
  • 市場評估
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章：執行摘要

第4章：簡介

第5章：全球新生兒篩檢市場

  • 市場概況
  • 市場表現
  • COVID-19的影響
  • 市場預測

第6章：市場區隔：依產品

  • 儀器
  • 試劑

第7章：市場區隔：依技術

  • 串聯質譜法
  • 脈搏血氧儀
  • 基於酵素的檢測
  • DNA檢測
  • 電泳
  • 其他

第 8 章：市場區隔：按測試類型

  • 乾血斑測試
  • 慢性腎臟病
  • 聽力篩檢

第9章：市場細分：依地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

第 10 章：SWOT 分析

第 11 章：價值鏈分析

第 12 章：波特五力分析

第13章：價格分析

第 14 章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Agilent Technologies Inc.
    • Baebies Inc.
    • Bio-RAD Laboratories Inc.
    • Chromsystems Instruments & Chemicals GmbH
    • Danaher Corporation
    • Masimo Corporation
    • Medtronic plc
    • Natus Medical Incorporated
    • Perkinelmer Inc.
    • RECIPE Chemicals + Instruments GmbH
    • Thermo Fisher Scientific Inc.
    • Trivitron Healthcare
    • Waters Corporation
Product Code: SR112025A4068

The global newborn screening market size was valued at USD 1,089.3 Million in 2024. Looking forward, IMARC Group estimates the market to reach USD 1,818.1 Million by 2033, exhibiting a CAGR of 5.9% from 2025-2033. North America currently dominates the market, holding a market share of over 33.2% in 2024. This is due to the increasing awareness among individuals toward early detection of severe diseases in newborns, improvements in medical technology for more accurate outcomes, and favorable government initiatives.

The newborn screening market is escalating due to the advent of technological advances in diagnostics and awareness regarding early identification of neonatal diseases. Governments around the world have undertaken programs for comprehensive screening at birth - metabolic, genetic, and endocrine disorders - which further increases the demand for advanced screening kits and systems for these disorders. Further extensions in the field of tandem mass spectrometry and enzyme-linked immunoassays have increased the sensitivity and specificity required by the tests and thus improved their overall adoption. The rising incidence of congenital anomalies and inherited metabolic disorders makes early diagnosis highly imperative, making this system a top priority in public health policy.

The United States has emerged as a key regional market for newborn screening. This is due to growing awareness about early disease detection and its role in preventing lifelong complications. Government initiatives mandating comprehensive newborn screening programs have been pivotal in driving adoption. Advances in technology, such as tandem mass spectrometry and next-generation sequencing, enhance the accuracy and speed of detecting genetic, metabolic, and infectious conditions, encouraging widespread use. The rising prevalence of genetic disorders and metabolic conditions further fuels demand. Increased public and private funding supports research and the implementation of advanced screening methods. Additionally, the development of non-invasive screening techniques offers safer and more efficient testing options. Moreover, healthcare providers and policymakers emphasize the long-term cost savings of early diagnosis and treatment, creating further momentum.

Newborn Screening Market Trends:

Increasing awareness about early disease detection

The growing awareness among parents toward the critical importance of early disease detection, as it helps in enhancing treatment outcomes, improving quality of life for the child, offering timely intervention represents one of the primary drivers bolstering the newborn screening market. Besides this, the rising occurrence of congenital diseases is also acting as another significant growth-inducing factor. Moreover, according to reports, about two to three children out of every 1000 children have cerebral palsy in the United States.

Favorable government initiatives

The launch of policies by regulatory authorities that often cover a comprehensive panel of disorders and ensure that potential health issues are addressed efficiently is bolstering the global newborn screening market. For example, in June 2022, government bodies in Manitoba, Canada, announced the expansion of their newborn screening program with an aim to extend screening for spinal muscular atrophy, along with other diseases. Moreover, various government authorities have also made newborn screening compulsory before getting discharged from the hospital, thereby positively impacting the overall newborn screening market growth.

Improvements in medical technology

Key players are advancing their medical technologies to improve newborn screening methods, which is acting as another significant growth-inducing factor. Moreover, emerging screening technologies encourage healthcare providers to offer and adopt these services, thereby fueling the global market. For example, in June 2021, the Texas Department of State Health Services introduced newborn screening for Spinal Muscular Atrophy (SMA). In line with this, in 2022, Trivitron Healthcare developed a Centre of Excellence (CoE) with state-of-the-art R&D and manufacturing facilities at AMTZ Campus in India for genomics, newborn screening, metabolomics, and molecular diagnostics. Furthermore, in January 2023, Masimo announced the launch of its new state-of-the-art baby monitoring system that allows caretakers to monitor the data of babies in real-time.

Newborn Screening Industry Segmentation:

Analysis by Product:

  • Instruments
  • Reagents

Instrument stand as the largest component in 2024, holding around 77.6% of the market. Instruments play a crucial role in the screening process for sample collection, analysis, result interpretation, etc. In addition to this, they comprise a wide array of technologies, such as deoxyribonucleic acid (DNA) analyzers, automated screening platforms, mass spectrometry systems, etc. Moreover, the rising investments by key healthcare companies in diagnostics tests that require instruments are expected to bolster the market growth in this segmentation. For instance, in March 2023, GC Labs announced the launch of its new test for the diagnosis of Inborn Errors of Metabolism (IEM) among newborns with the integration of novel disease detection methods.

Analysis by Technology:

  • Tandem Mass Spectrometry
  • Pulse Oximetry
  • Enzyme Based Assay
  • DNA Assay
  • Electrophoresis
  • Others

Tandem mass spectrometry leads the market with around 23.8% of the newborn screening market share in 2024. Tandem mass spectrometry refers to an analytical technique that is employed in newborn screening to identify several metabolic disorders. In line with this, it provides improved accuracy and speed. Numerous technological advancements in the medical field enhance tandem mass spectrometry, which will continue to drive the market growth in this segmentation. For example, in April 2023, Waters Corporation announced the development of its new Xevo TQ Absolute IVD Mass Spectrometer for clinical applications.

Analysis by Test Type:

  • Dry Blood Spot Test
  • CCHD
  • Hearing Screen

Dry blood spot test leads the market with around 46.5% of market share in 2024. A dry blood spot test refers to a non-invasive screening technique that generally involves collecting a small amount of blood from the heel of a newborn onto a special filter paper. The dried blood sample is then analyzed for the presence of specific markers associated with several disorders. The test is widely preferred among newborn screening programs, as it provides ease of transportation, convenience of sample collection, and the ability to simultaneously screen for various conditions. Besides this, the elevating number of initiatives by government bodies is acting as another significant growth-inducing factor in this segmentation.

Regional Analysis:

  • North America
    • United States
    • Canada
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

In 2024, North America accounted for the largest market share of over 33.2%. The increasing prevalence of congenital disabilities in North America is augmenting the need for newborn screening. Moreover, the implementation of stringent regulations by government bodies across the region is also acting as another significant growth-inducing factor. For example, according to the March of Dimes (MoD) report of 2021, before leaving the hospital, every baby in the United States went through the screening process. Apart from this, the elevating focus of key players on preventive healthcare is inflating the popularity of advanced technologies, which is expected to bolster the North America newborn screening market over the foreseeable future.

Key Regional Takeaways:

United States Newborn Screening Market Analysis

In 2024, the United States accounts for 86.80% of the newborn screening market in North America. Most insurance plans across the United States are covering newborn screening tests, which is contributing to its accessibility. This is providing an impetus to the market growth. In line with this, awareness campaigns and healthcare initiatives across the United States are continuously growing to improve early diagnosis, particularly among parents and healthcare providers. This is further fueling the market growth. According to reports, each year, approximately 8,000 to 10,000 newborns across the United States are diagnosed with cerebral palsy. Moreover, 764,000 number of children are diagnosed with cerebral palsy in the United States of America. In addition to this, the adoption of advanced diagnostic tools such as tandem mass spectrometry across the region is fueling the newborn screening market. Furthermore, newborn screening is being mandated by law in all the states situated across the United States of America for several diseases thereby leading to high screening coverage. This, in turn, is impelling the market growth.

Asia Pacific Newborn Screening Market Analysis

Several countries located across the Asia-Pacific region have established their nationwide newborn screening programs while others are in the process of expanding their programs. This is providing an impetus to the market growth. In line with this, healthcare systems particularly in urban areas across this region are propelling the reach of newborn screening programs. According to the National Bureau of Statistics of China, by the end of 2023, the national population totaled 1,409.67 Million, with urban permanent residents accounting for 932.67 Million. Additionally, the rising incidences of genetic disorders across this region are escalating the growing demand for early detection methods. This, in turn, is impelling the market growth. Furthermore, there is an increasing awareness among healthcare providers and the general public regarding the importance of newborn screening, proliferating its adoption and implementation.

Europe Newborn Screening Market Analysis

Many European countries are implementing national screening programs, ensuring that almost all newborns are being tested. This, in turn, is impelling the market growth. According to the British Medical Association, one in every 1000 children residing across the United Kingdom are diagnosed with autism spectrum disorder. Moreover, according to reports, in England and Wales, with an annual birth rate of approximately 700,000, there could be up to 1,700 new cases of cerebral palsy diagnosed in children each year. In line with this, European Union regulations and directives are supporting newborn screening, ensuring its adoption and standardization. This is providing an impetus to the market growth. Additionally, the use of high-throughput technologies across the European region, such as dry blood spot screening and tandem mass spectrometry, is continuously increasing. Owing to this, the market growth is augmenting. Furthermore, NGOs and healthcare agencies in Europe are actively advocating for the expansion of the scope of newborn screening.

Latin America Newborn Screening Market Analysis

Latin American countries are following newborn screening programs thereby ensuring that the newborns are being tested. This is providing an impetus to the market growth. According to the National Institutes of Health (NIH), in Brazil, there are approximately 4 Million pediatric pneumonia cases reported annually. In line with this, there is a growing awareness about the importance of early detection of diseases among infants which is being driven by healthcare NGOs and international organizations. This, in turn, is impelling the market growth.

Middle East and Africa Newborn Screening Market Analysis

Newborn screening is increasingly becoming mandatory across the region so that the list of disorders screened can be expanded. According to a survey, a total of 613 children diagnosed with cerebral palsy were identified, with a higher prevalence among males. Moreover, the median age at which children at risk for cerebral palsy were identified was 9 weeks. In addition to this, governments across the region are investing in healthcare infrastructure, which includes expanding newborn programs. This, in turn, is impelling the market growth.

Competitive Landscape:

Companies are investing in cutting-edge technologies, such as next-generation sequencing (NGS) and mass spectrometry, to enhance the accuracy and efficiency of screening processes. These advancements enable early detection of a broader range of disorders, meeting growing healthcare demands. Moreover, key players are introducing comprehensive screening panels and user-friendly devices tailored to healthcare providers' needs. These expanded offerings increase market appeal and address diverse customer requirements. Besides, strategic partnerships with healthcare institutions, research organizations, and government agencies allow companies to drive innovation and expand their market presence. Collaborations also facilitate better adoption of screening programs globally.

The report provides a comprehensive analysis of the competitive landscape in the newborn screening market with detailed profiles of all major companies, including:

  • Agilent Technologies Inc.
  • Baebies Inc.
  • Bio-RAD Laboratories Inc.
  • Chromsystems Instruments & Chemicals GmbH
  • Danaher Corporation
  • Masimo Corporation
  • Medtronic plc
  • Natus Medical Incorporated
  • Perkinelmer Inc.
  • RECIPE Chemicals + Instruments GmbH
  • Thermo Fisher Scientific Inc.
  • Trivitron Healthcare
  • Waters Corporation

Key Questions Answered in This Report

  • 1.What is newborn screening?
  • 2.How big is the global newborn screening market?
  • 3.What is the expected growth rate of the global newborn screening market during 2025-2033?
  • 4.What are the key factors driving the global newborn screening market?
  • 5.What is the leading segment of the global newborn screening market based on product?
  • 6.What is the leading segment of the global newborn screening market based on technology?
  • 7.What is the leading segment of the global newborn screening market based on test type?
  • 8.What are the key regions in the global newborn screening market?
  • 9.Who are the key players/companies in the global newborn screening market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Newborn Screening Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Instruments
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Reagents
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Technology

  • 7.1 Tandem Mass Spectrometry
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Pulse Oximetry
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Enzyme Based Assay
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 DNA Assay
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Electrophoresis
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Others
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast

8 Market Breakup by Test Type

  • 8.1 Dry Blood Spot Test
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 CCHD
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Hearing Screen
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Agilent Technologies Inc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Baebies Inc.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 Bio-RAD Laboratories Inc.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Chromsystems Instruments & Chemicals GmbH
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
    • 14.3.5 Danaher Corporation
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 Masimo Corporation
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Medtronic plc
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Natus Medical Incorporated
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Perkinelmer Inc.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 RECIPE Chemicals + Instruments GmbH
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
    • 14.3.11 Thermo Fisher Scientific Inc.
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
      • 14.3.11.4 SWOT Analysis
    • 14.3.12 Trivitron Healthcare
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
    • 14.3.13 Waters Corporation
      • 14.3.13.1 Company Overview
      • 14.3.13.2 Product Portfolio
      • 14.3.13.3 Financials
      • 14.3.13.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Newborn Screening Market: Major Drivers and Challenges
  • Figure 2: Global: Newborn Screening Market: Sales Value (in Million USD), 2019-2024
  • Figure 3: Global: Newborn Screening Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 4: Global: Newborn Screening Market: Breakup by Product (in %), 2024
  • Figure 5: Global: Newborn Screening Market: Breakup by Technology (in %), 2024
  • Figure 6: Global: Newborn Screening Market: Breakup by Test Type (in %), 2024
  • Figure 7: Global: Newborn Screening Market: Breakup by Region (in %), 2024
  • Figure 8: Global: Newborn Screening (Instruments) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 9: Global: Newborn Screening (Instruments) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 10: Global: Newborn Screening (Reagents) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: Newborn Screening (Reagents) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: Newborn Screening (Tandem Mass Spectrometry) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: Newborn Screening (Tandem Mass Spectrometry) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: Newborn Screening (Pulse Oximetry) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: Newborn Screening (Pulse Oximetry) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: Newborn Screening (Enzyme Based Assay) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: Newborn Screening (Enzyme Based Assay) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: Newborn Screening (DNA Assay) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: Newborn Screening (DNA Assay) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: Newborn Screening (Electrophoresis) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: Newborn Screening (Electrophoresis) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: Global: Newborn Screening (Other Technologies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: Global: Newborn Screening (Other Technologies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: Global: Newborn Screening (Dry Blood Spot Test) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: Global: Newborn Screening (Dry Blood Spot Test) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: Global: Newborn Screening (CCHD) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: Global: Newborn Screening (CCHD) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: Global: Newborn Screening (Hearing Screen) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: Global: Newborn Screening (Hearing Screen) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: North America: Newborn Screening Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: North America: Newborn Screening Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: United States: Newborn Screening Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: United States: Newborn Screening Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: Canada: Newborn Screening Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: Canada: Newborn Screening Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: Asia-Pacific: Newborn Screening Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: Asia-Pacific: Newborn Screening Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: China: Newborn Screening Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: China: Newborn Screening Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: Japan: Newborn Screening Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: Japan: Newborn Screening Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: India: Newborn Screening Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: India: Newborn Screening Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: South Korea: Newborn Screening Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: South Korea: Newborn Screening Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: Australia: Newborn Screening Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: Australia: Newborn Screening Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: Indonesia: Newborn Screening Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: Indonesia: Newborn Screening Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: Others: Newborn Screening Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: Others: Newborn Screening Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: Europe: Newborn Screening Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: Europe: Newborn Screening Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: Germany: Newborn Screening Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: Germany: Newborn Screening Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: France: Newborn Screening Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: France: Newborn Screening Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 58: United Kingdom: Newborn Screening Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 59: United Kingdom: Newborn Screening Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 60: Italy: Newborn Screening Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 61: Italy: Newborn Screening Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 62: Spain: Newborn Screening Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 63: Spain: Newborn Screening Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: Russia: Newborn Screening Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 65: Russia: Newborn Screening Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: Others: Newborn Screening Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 67: Others: Newborn Screening Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: Latin America: Newborn Screening Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 69: Latin America: Newborn Screening Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 70: Brazil: Newborn Screening Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 71: Brazil: Newborn Screening Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 72: Mexico: Newborn Screening Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 73: Mexico: Newborn Screening Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 74: Others: Newborn Screening Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 75: Others: Newborn Screening Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 76: Middle East and Africa: Newborn Screening Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 77: Middle East and Africa: Newborn Screening Market: Breakup by Country (in %), 2024
  • Figure 78: Middle East and Africa: Newborn Screening Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 79: Global: Newborn Screening Industry: SWOT Analysis
  • Figure 80: Global: Newborn Screening Industry: Value Chain Analysis
  • Figure 81: Global: Newborn Screening Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Newborn Screening Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Newborn Screening Market Forecast: Breakup by Product (in Million USD), 2025-2033
  • Table 3: Global: Newborn Screening Market Forecast: Breakup by Technology (in Million USD), 2025-2033
  • Table 4: Global: Newborn Screening Market Forecast: Breakup by Test Type (in Million USD), 2025-2033
  • Table 5: Global: Newborn Screening Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 6: Global: Newborn Screening Market: Competitive Structure
  • Table 7: Global: Newborn Screening Market: Key Players